Lappe Mark
Chief Executive Officer at Inhibrx, Inc.; 10% owner at REPROS THERAPEUTICS INC.
- Sold, on record
- $5.2M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Feb 28, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Inhibrx, Inc.Chief Executive Officer
- REPROS THERAPEUTICS INC.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- REPROS THERAPEUTICS INC.688,157 shares
- Inhibrx, Inc.78,060 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale REPROS THERAPEUTICS INC.Plan not statedMar 27, 2008 2008
Sold 302,057 shares at $9.21 ($2.8M)
Lappe Mark, 10% owner
Sold 11.7% of holdings ($23.8M position)2.3M shares leftFirst sale on recordFiling
- 2 Form 4 sale REPROS THERAPEUTICS INC.Plan not statedDec 15, 2009 +628 days
Sold 386,100 shares at $0.69 ($265k)
Lappe Mark, 10% owner
Sold 12.5% of holdings ($2.1M position)2.7M shares leftFiling
- 3 Form 4 sale Inhibrx, Inc.Plan not statedOct 17, 2022 +4689 days
Sold 26,000 shares at $29.59 ($769k)
Lappe Mark, Chief Executive Officer
Sold 1% of holdings ($76.6M position)2.6M shares leftFirst sale on recordFiling
- 4 Form 4 sale Inhibrx, Inc.Plan not statedNov 17, 2022 +31 days
Sold 26,000 shares at $27.88 ($725k)
Lappe Mark, Chief Executive Officer
Sold 1% of holdings ($71.5M position)2.5M shares leftFiling
- 5 Form 4 sale Inhibrx, Inc.Plan not statedDec 19, 2022 +32 days
Sold 26,000 shares at $25.55 ($664k)
Lappe Mark, Chief Executive Officer
Sold 1% of holdings ($64.9M position)2.5M shares leftFiling
- 6 Form 4 sale Inhibrx, Inc.Plan not statedFeb 28, 2023 +71 days
Sold 60 shares at $25.02 ($2k)
Lappe Mark, Chief Executive Officer
Sold 0% of holdings ($62.2M position)2.5M shares left0x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2023 | Mar 1, 2023 | Inhibrx, Inc. | Chief Executive Officer | Form 4 sale | 60 | $2k | 0.0% | Plan not stated | SEC |
| Dec 19, 2022 | Dec 20, 2022 | Inhibrx, Inc. | Chief Executive Officer | Form 4 sale | 26,000 | $664k | 1.0% | Plan not stated | SEC |
| Nov 17, 2022 | Nov 18, 2022 | Inhibrx, Inc. | Chief Executive Officer | Form 4 sale | 26,000 | $725k | 1.0% | Plan not stated | SEC |
| Oct 17, 2022 | Oct 18, 2022 | Inhibrx, Inc. | Chief Executive Officer | Form 4 sale | 26,000 | $769k | 1.0% | Plan not stated | SEC |
| Dec 15, 2009 | Dec 15, 2009 | REPROS THERAPEUTICS INC. | 10% owner | Form 4 sale | 386,100 | $265k | 12.5% | Plan not stated | SEC |
| Mar 27, 2008 | Jul 3, 2008 | REPROS THERAPEUTICS INC. | 10% owner | Form 4 sale | 302,057 | $2.8M | 11.7% | Plan not stated | SEC |